Sundar PichaiSundar Pichai earned $164M in 2023

Kevin Conroy is the former CEO of Exact Sciences Corp, a company that specializes in the field of biotechnology and diagnostics. He joined the company in 2009, during a pivotal time when the company was looking to build its strategic...

Quick Links
E

Kevin Conroy

Ex-CEO of Exact Sciences

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of Exact Sciences for

8 years 5 months (Jul 2014 - Dec 2022)

Previous Experience

President and Chief Executive Officer at Exact Sciences Corporation, various leadership roles at Exact Sciences Corporation

Rivals

Competitors/colleagues of Kevin Conroy

Holdings

See how much did Kevin Conroy make over time.

During his tenure, Conroy's holdings in Exact Sciences demonstrated notable fluctuations. In 2019, his total holdings reached a staggering value of up to $102.95 million. However, by early 2022, this figure saw a downward trend, dropping to around $53.78 million....

No data yet.

No data yet.

Total Stock Sold

$172.69M

EXAS

$172.69M

3,161,913 EXAS shares

What if they kept their stock?

If Kevin Conroy didn't sell their stock, today they would have:
Extra EXAS3,161,913 shares worth $309.55M.
This is 79.25% and $136.86M more than what they got when they sold the stock.

Charitable Transactions

EXAS

186,304 shares

EXAS

Recent Charitable Transactions

EXAS

35,750 shares

EXAS

Feb 1, 2021

Charity

EXAS

65,189 shares

EXAS

Dec 31, 2019

Charity

EXAS

2,522 shares

EXAS

Dec 31, 2015

Charity

EXAS

68,332 shares

EXAS

Dec 31, 2014

Charity

EXAS

4,092 shares

EXAS

Dec 31, 2013

Charity

EXAS

1,500 shares

EXAS

Dec 26, 2012

Charity

Insider Trading

See recent insider trades of Kevin Conroy.

EXAS

$69.47K

EXAS at $60.15/share

Apr 30, 2024

Sale

EXAS

$47.99K

EXAS at $15.01/share

Apr 30, 2024

Received

EXAS

$490.64K

EXAS at $59.32/share

Feb 29, 2024

Sale

EXAS

$356.30K

EXAS at $56.89/share

Feb 26, 2024

Sale

EXAS

$691.36K

EXAS at $59.78/share

Feb 21, 2024

Sale

EXAS

23,238 shares

EXAS

Feb 21, 2024

Received

EXAS

$305.96K

EXAS at $61.50/share

Feb 20, 2024

Sale

EXAS

$908.61K

EXAS at $61.43/share

Feb 14, 2024

Sale

EXAS

$21.28K

EXAS at $30.02/share

Feb 14, 2024

Received

Compensation History

See how much did Kevin Conroy make over time.

Kevin Conroy’s compensation package over the years showcased a mix of salary, bonuses, and stock options that aligned his interests with those of the shareholders. For instance, in 2020, his total compensation reported was approximately $20.12 million, largely driven by performance metrics during the pandemic which impacted cash bonuses and stock vesting. His cash salary started at $340,000 in 2009 with bonuses tied to company performance that often exceeded targets. By 2022, his total annual compensation was around $1.45 million, combining a salary, cash bonus based on corporate performance, and the value of vested stock options. This reflects a pattern that emphasizes incentivizing executives to focus on the long-term health of the company rather than just short-term gains, fostering a culture of shared success and accountability.

Year

2022

Total Compensation

$6.16M

Salary

$1.00M

Board Justification

The compensation program is designed to attract, motivate, and retain executive officers, with a significant portion of compensation being performance-based and aligned with shareholder interests.

Bonus

$749.25K

Board Justification

In 2022, Mr. Conroy received a cash bonus of $749,245 based on the achievement of corporate goals established for the annual cash bonus plan.

Other

$279.42K

Board Justification

Other compensation includes a matching contribution to the 401(k) plan, reimbursement for business expenses, and travel expenses paid by the Company.

Restricted Stock

$4.13M(52.72K RSU)

Board Justification

In 2022, Mr. Conroy received 52,722 RSUs that vested in eleven equal monthly installments from February 2022 through December 2022, as part of his base salary compensation.

Performance Metrics

The performance metrics for 2022 included revenue growth, achievement of corporate goals, and overall company performance.